MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2024 International Congress

    Pure Autonomic Failure As a Severe “Body-First Subtype” of Lewy Body Disease: A Multimodal Imaging Study of the Autonomic Nervous System

    C. Skjaerbaek, I. Cani, K. Knudsen, G. Carrozzo, P. Guaraldi, T. Lillethorup, T. Fedorova, A. Terkelsen, P. Cortelli, P. Borghammer (Aarhus, Denmark)

    Objective: Using multi-modal imaging this study aimed to characterize the deterioration of the parasympathetic and sympathetic nervous system in pure autonomic failure (PAF) in comparison…
  • 2024 International Congress

    Mapping Cholinergic Signaling in Parkinson Disease Using [18F]VAT

    J. O'Donnell, M. Campbell, S. Norris, B. Maiti, A. Soda, S. Moerlein, Z. Tu, J. Perlmutter (St. Louis, USA)

    Objective: To determine how cholinergic signaling changes within Parkinson Disease (PD) and how these differences relate to the progression of cognitive and behavioral symptoms. Background:…
  • 2024 International Congress

    Correlation of lmaging Markers with Clinical Features in Multiple System Atrophy Patients

    N. Jin (Hangzhou, China)

    Objective: This study aims to investigate the correlation between visually assessable imaging markers and their clinical symptoms in Multiple System Atrophy (MSA) patients. Background: MSA is…
  • 2024 International Congress

    Neuroimaging Factors Differentially Associated with Pathology and Clinical Presentation

    J. Pommy, S. Bouchachi, A. Bryant, V. Thornton, C. Nguyen, J. Truelove, K. Rawson, J. Icehour, M. Knopp, C. Wright, D. Scharre (Columbus, USA)

    Objective: Examine utility of a factor analysis approach to neuroimaging data in Lewy body disease (LBD) and Alzheimer’s disease (AD). Background: Significant heterogeneity exists among patients…
  • 2024 International Congress

    Cardiac Mitochondrial Complex I Integrity Predicts Axial Symptom Severity in Parkinson’s Disease

    S. Roytman, G. Carli, R. Vangel, P. Kanel, R. Koeppe, N. Bohnen (Ann Arbor, USA)

    Objective: In the present work, we investigated whether cardiac mitochondrial dysfunction might also be associated with the severity of PIGD symptoms in PD patients. Background:…
  • 2024 International Congress

    Optical Coherence Tomography Findings in Multiple System Atrophy: Insights into Disease Subtypes, Clinical Correlations, and Dopaminergic Degeneration

    Y. Kang (Hangzhou, China)

    Objective: This study aimed to evaluate optical coherence tomography (OCT) findings in multiple system atrophy (MSA) patients, with a focus on disease subtypes, clinical correlations,…
  • 2024 International Congress

    The dementia with Lewy bodies related metabolic brain pattern (DLBRP) – a multicentric validation

    M. Perovnik, U. Simončič, H. Kos, J. Jamšek, M. Kramberger, M. Brendel, V. Camacho, R. Vandenberghe, V. Garibotto, M. Ochoa-Figueroa, A. Padovani, S. Morbelli, D. Ferreira, M. Trošt (Ljubljana, Slovenia)

    Objective: Dementia with Lewy bodies-related pattern (DLBRP) has been identified from the FDG PET brain imaging of DLB patients and healthy controls previously. A multicentric…
  • 2024 International Congress

    Distinguishing Parkinson’s disease from atypical Parkinsonian syndrome using multistage deep learning based on dopamine transporter imaging

    JS. Park, JY. Gwak (Busan, Republic of Korea)

    Objective: We made the diagnostic model using a deep learning algorithm based on dopamine transporterWe made the diagnostic model using a deep learning algorithm based…
  • 2024 International Congress

    Longitudinal progress and clinical relevance of 18F-Florzolutau PET in patients with PSP: a one-year follow-up study

    J. Wang, F. Liu, C. Zuo (Shanghai, China)

    Objective: Here we aimed to explore the progress of 18F-Florzolotau PET and its clinical relevance in patients with PSP during one-year follow-up. Background: The 18F-Florzolotau…
  • 2024 International Congress

    The Next Move in Movement Disorders: Differentiating between Hyperkinetic Movement Disorders using [18F] FDG PET

    J. Dalenberg, D. Peretti, L. Marapin, S. Jonker, E. Timmers, A. Vander Stouwe, M. Tijssen (Groningen, Netherlands)

    Objective: Understanding the differences in brain glucose metabolism between hyperkinetic movement disorders. Background: The Next Move in Movement Disorders (NEMO) study is a research initiative…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley